Johnson & Johnson (J&J) has earned FDA approval for a first-of-its-kind daily psoriasis pill whose benefits rival those of injectable treatments, in today’s bite-sized hospital and health industry news from California, Maryland, and New Jersey. California: Structure Therapeutics last week reported that its daily obesity pill led patients to lose roughly 16% of their body […]

Author